Page 2 - ISNI abstracts

International Joint Israel-Greek-Italian Neuroimmunological meeting Contents From Anti VLA-4 therapy to chemokine based potentiation of Tregs for treating MS 3 Autologous Regulatory (Treg) Cells Generated Ex-vivo, Suppress Autoimmune Diseases 4 Differential Modulation of the Juxtaparanodal Complex in Multiple Sclerosis 5 Foxp3hiCD45RA-CD39+ Treg cells in Multiple Sclerosis 6 Fumarates Modulate Microglia Activation through a Novel HCAR2 Signaling Pathway and Rescue Synaptic Dysregulation in Inflamed CNS 7 Crucial Role of IL-1β βIL-1R in The Fine-Tune Modulation of Th17 Features in Multiple Sclerosis 8 Immunomodulation by a Tolerogenic Recombinant Fusion Protein Containing Acetylcholine Receptor Tcell-epitope 146-162 in Mouse Experimental Myasthenia Gravis 9 From synthetic glycopeptides to the discovery of bacterial proteins cross-reacting with anti-N(Glucosylation) antibodies in Multiple Sclerosis 10 Immunogenetics of Pediatric Multiple Sclerosis: Towards a Personalized Theurapeutic 11 Approach NG2, expressed by immune and neural cells, displays multiple roles in development of Experimental Autoimmune Encephalomyelitis 12 The spectrum of post vaccination inflammatory CNS demyelinating syndromes 13 Tracking inflammation in the epileptic rat brain by bi-functional nanoparticles 14 Prion like aggregation of MBP in chronic demyelination 15 miRNAs shuffled by exomes derived from immunomodulatory mesenchymal stem cells modulate activation of microglia 16 Glatiramer Acetate Depot: Towards Clinical Application 17 2